GlobeImmune, Inc is a biopharmaceutical company which recently filed with the SEC to go public, but have still not begun trading. The company was founded in 1995 as Ceres Pharmaceutical and changed its name to GlobeImmune in 2001. GlobeImmune has the ambitious goal of ending disease all over the world. At the moment GlobeImmune is… Continue Reading